Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
0.00%
Variazione Mensile
-3.39%
Variazione di 6 mesi
+50.00%
Variazione Annuale
-65.45%
Chiusura Precedente
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volume
5
Mercati
Mercato Azionario Statunitense
Salute
FEMY
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
11.8 M
11.87 M
22.1 M
27.15 M
—
Valuation ratios
Enterprise value
21.25 M
-2.28 M
604.26 K
26.41 M
100.93 M
Price to earnings ratio
-3.48
-0.94
-1.09
-1.29
-4.28
Price to sales ratio
22.19
8.82
14.5
15.04
48.96
Price to cash flow ratio
-3.3
-0.99
-1.38
-1.26
-4.41
Price to book ratio
0.99
0.7
0.85
10.63
14.87
Enterprise value to EBITDA ratio
-2.75
0.21
-0.04
-1.62
-5.92
Profitability ratios
Return on assets %
-0.26
-0.67
-0.51
-1.51
-1.45
Return on equity %
-0.29
-0.75
-0.78
-8.17
-9.14
Return on invested capital %
-929.89
-1 343.28
-1 386.43
-919.33
-721.05
Gross margin %
68.6
63.36
64.54
66.55
253.62
Operating margin %
-706.7
-961.71
-1 353.43
-1 091.75
-3 854.16
EBITDA margin %
-655.02
-913.66
-1 297.16
-1 000.3
-3 459.99
Net margin %
-638.97
-944.62
-1 329.06
-1 155.03
-4 304.57
Liquidity ratios
Quick ratio
15.02
8.96
7.37
0.58
2.14
Current ratio
15.15
9.25
7.59
0.93
3.91
Inventory turnover
1.78
1.37
0.69
0.29
0.2
Asset turnover
0.04
0.05
0.05
0.08
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.01
0.15
0
0.89
Long term debt to total equity ratio
0
0.01
0.23
0
6.98
Per share metrics
Operating cash flow per share
-1.18
-0.91
-0.73
-0.87
-0.7
EBIT per share
-1.24
-0.98
-0.94
-0.8
-0.65
EBITDA per share
-1.15
-0.93
-0.9
-0.73
-0.59
Total debt per share
—
—
—
—
—
Cash per share
3.69
1.1
1.41
0.16
0.53
Net current asset value per share
3.82
1.2
1.51
0.36
1.36
Tangible book value per share
3.92
1.29
1.19
0.1
0.34
Working capital per share
3.57
1.07
1.31
-0.03
-0.05
Book value per share
3.92
1.29
1.19
0.1
0.35
Notizie
Femasys riceve approvazione codice CPT per trattamento infertilità
Femasys receives CPT code approval for infertility treatment
Le azioni Femasys salgono grazie a una nuova partnership di distribuzione in Svizzera
Femasys expands European presence with Swiss distribution deal
Femasys ottiene una proroga di 180 giorni dal Nasdaq per rispettare la regola del prezzo minimo
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys collabora con Refuah Health Center per espandere il trattamento di fertilità FemaSeed
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
Il titolo di PharmaCyte Biotech vola dopo la vendita della quota in Femasys